Cargando…

Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint

To date, there are no clinically effective neuroprotective or disease-modifying treatments that can halt Parkinson's disease (PD) progression. The current clinical approach focuses on symptomatic management. This failure may relate to the complex neurobiology underpinning the development of PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Sportelli, Carolina, Urso, Daniele, Jenner, Peter, Chaudhuri, K. Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304367/
https://www.ncbi.nlm.nih.gov/pubmed/32595595
http://dx.doi.org/10.3389/fneur.2020.00556

Ejemplares similares